ADPT · Categories · Form 4
ADPT - SEC Form 4 insider transactions
Adaptive Biotechnologies Corporation (ADPT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ADPT
- Chief Financial Officer Piskel Kyle sold $40,620 worth of shares (3,115 units at $13.04), decreasing direct ownership by 1% to 256,725 units (SEC Form 4) to satisfy tax liability4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie sold $270,897 worth of shares (19,037 units at $14.23) as part of a pre-agreed trading plan and exercised 14,707 shares at a strike of $8.46, decreasing direct ownership by 1% to 377,802 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 44,166 shares at a strike of $8.46 and sold $798,423 worth of shares (57,180 units at $13.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 382,132 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Lo Francis4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Robins Harlan S4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Robins Chad M4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- SEC Form 4 filed by Rubinstein Julie4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 44,166 shares at a strike of $6.55 and sold $2,374,058 worth of shares (179,703 units at $13.21), decreasing direct ownership by 21% to 507,934 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee sold $214,131 worth of shares (15,394 units at $13.91), decreasing direct ownership by 50% to 15,625 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis sold $430,749 worth of shares (30,593 units at $14.08), decreasing direct ownership by 10% to 291,374 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan sold $544,421 worth of shares (41,338 units at $13.17), decreasing direct ownership by 9% to 427,775 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon sold $831,067 worth of shares (63,103 units at $13.17), decreasing direct ownership by 19% to 272,751 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle sold $245,910 worth of shares (18,672 units at $13.17), decreasing direct ownership by 7% to 259,840 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $6,193,403 worth of shares (470,266 units at $13.17), decreasing direct ownership by 24% to 1,522,058 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $6,192,099 worth of shares (470,167 units at $13.17), decreasing direct ownership by 17% to 2,301,113 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 68,328 shares at a strike of $8.53 and sold $1,211,737 worth of shares (81,342 units at $14.90), decreasing direct ownership by 2% to 643,471 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis sold $574,537 worth of shares (38,074 units at $15.09), decreasing direct ownership by 11% to 321,967 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Neupert Peter M was granted 15,625 shares, increasing direct ownership by 7% to 240,315 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Hershberg Robert was granted 15,625 shares, increasing direct ownership by 33% to 62,347 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis was granted 44,063 shares, increasing direct ownership by 14% to 360,041 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Officer, MRD Bobulsky Susan was granted 121,875 shares, increasing direct ownership by 35% to 469,113 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon was granted 39,063 shares, increasing direct ownership by 13% to 335,854 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie was granted 81,250 shares, increasing direct ownership by 14% to 656,485 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S was granted 837,033 shares, increasing direct ownership by 72% to 1,992,324 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle was granted 61,875 shares, increasing direct ownership by 29% to 278,512 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Owen Katey Einterz was granted 15,625 shares, increasing direct ownership by 22% to 88,254 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee was granted 15,625 shares, increasing direct ownership by 102% to 31,019 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M was granted 837,033 shares, increasing direct ownership by 43% to 2,771,280 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Griffin Michelle Renee exercised 48,044 shares at a strike of $3.99 and sold $735,073 worth of shares (48,044 units at $15.30) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- President and COO Rubinstein Julie exercised 79,809 shares at a strike of $9.05 and sold $1,493,428 worth of shares (92,823 units at $16.09), decreasing direct ownership by 2% to 575,235 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $392,329 worth of shares (24,233 units at $16.19), decreasing direct ownership by 2% to 1,155,291 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $8,320,613 worth of shares (524,998 units at $15.85), decreasing direct ownership by 21% to 1,934,247 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle exercised 2,145 shares at a strike of $12.14 and sold $39,597 worth of shares (2,145 units at $18.46) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $799,105 worth of shares (42,788 units at $18.68), decreasing direct ownership by 4% to 1,179,524 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $2,304,963 worth of shares (124,998 units at $18.44), decreasing direct ownership by 5% to 2,459,245 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 79,590 shares at a strike of $7.71 and sold $1,411,131 worth of shares (79,590 units at $17.73) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle exercised 4,290 shares at a strike of $12.14 and sold $77,220 worth of shares (4,290 units at $18.00) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $164,400 worth of shares (10,000 units at $16.44), decreasing direct ownership by 0.81% to 1,222,312 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Amendment: Chief People Officer Lo Francis exercised 4,394 shares at a strike of $6.06 and sold $76,895 worth of shares (4,394 units at $17.50) (SEC Form 4)4/A - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $1,948,719 worth of shares (124,998 units at $15.59), decreasing direct ownership by 5% to 2,584,243 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 3,125 shares at a strike of $3.99 and sold $50,250 worth of shares (3,125 units at $16.08) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 4,394 shares at a strike of $7.18 and sold $76,895 worth of shares (4,394 units at $17.50) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief People Officer Lo Francis exercised 97,022 shares at a strike of $6.37 and sold $1,773,267 worth of shares (113,890 units at $15.57), decreasing direct ownership by 5% to 315,978 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Director Hershberg Robert sold $367,488 worth of shares (22,968 units at $16.00), decreasing direct ownership by 33% to 46,722 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon exercised 12,604 shares at a strike of $8.24 and sold $212,377 worth of shares (12,604 units at $16.85) (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $672,515 worth of shares (37,212 units at $18.07), decreasing direct ownership by 3% to 1,232,312 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle exercised 110,114 shares at a strike of $11.38 and sold $3,174,990 worth of shares (162,820 units at $19.50), decreasing direct ownership by 20% to 216,637 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $3,070,747 worth of shares (160,734 units at $19.10), decreasing direct ownership by 6% to 2,709,241 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Commercial Ofc Imm Med Benzeno Sharon exercised 510,470 shares at a strike of $8.75 and sold $10,144,026 worth of shares (606,402 units at $16.73), decreasing direct ownership by 24% to 296,791 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Financial Officer Piskel Kyle sold $3,344 worth of shares (238 units at $14.05), decreasing direct ownership by 0.09% to 269,343 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- Chief Scientific Officer Robins Harlan S sold $148,200 worth of shares (10,000 units at $14.82), decreasing direct ownership by 0.78% to 1,269,524 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
- CEO and Chairman Robins Chad M sold $1,315,180 worth of shares (89,265 units at $14.73), decreasing direct ownership by 3% to 2,869,975 units (SEC Form 4)4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)